This is a permanent results page for your analyzed data. Please save the link in your browser's address bar.
| Title / Description | Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2 |
| Accession | GSE28645 |
| Summary | Analysis of endocrine-resistant LY2 breast cancer cells depleted of p160 steroid coactivator protein SRC-1 and treated with tamoxifen. SRC-1 is central to the development of the endocrine resistant phenotype. Results provide insight into the molecular basis of endocrine resistant breast cancer. |
| Organism | Homo sapiens |
| Platform | GPL570 |
| Normalized | False |
| Parsed SOFT file |
| Differential expression method | Characteristic Direction |
| Cutoff | 500 |
| Gene | NCOA1 |
| Cell | Breast Cancer |
| Perturbation | Tamoxifen |
| Disease | Breast Cancer |
| Gene lists | Enrichr | L1000CDS2 | PAEA | |
| Up |
|
|||
| Down |
|
|||
| Combined |
|
|
|
